Zevra Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.157; its P/E ratio is -5.13; Zevra Therapeutics is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 2.90M	$ 8.47M	$ 2.88M	$ 2.32M	$ 2.87M
Gross Profit	$ 2.75M	$ 8.47M	$ 125.00K	$ -143.00K	$ 2.73M
EBIT	$ -13.50M	$ -4.96M	$ -12.93M	$ -9.80M	$ -6.53M
EBITDA	-	$ -4.88M	$ -12.85M	$ -9.50M	$ -6.13M
Net Income Common Stockholders	$ -14.04M	$ -5.08M	$ 19.84M	$ -9.02M	$ -6.62M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 83.43M	$ 87.37M	$ 95.28M	$ 82.85M	$ 75.89M
Total Assets	$ 138.98M	$ 105.52M	$ 106.59M	$ 115.53M	$ 119.55M
Total Debt	$ 44.82M	$ 13.79M	$ 14.12M	$ 14.12M	$ 14.23M
Net Debt	$ -38.60M	$ -73.58M	$ -81.16M	$ -68.72M	$ -61.66M
Total Liabilities	$ 71.51M	$ 37.02M	$ 35.19M	$ 29.72M	$ 25.76M
Stockholders Equity	$ 67.47M	$ 68.50M	$ 71.40M	$ 85.81M	$ 93.79M
Cash Flow	-
Free Cash Flow	-	$ -8.83M	$ -3.97M	$ -4.50M	$ -6.63M
Operating Cash Flow	$ -4.63M	$ -8.81M	$ -3.94M	$ -4.46M	$ -6.60M
Investing Cash Flow	$ -44.46M	$ 34.04M	$ -17.55M	$ -63.00K	$ 272.00K
Financing Cash Flow	$ 26.26M	$ 951.00K	$ -3.75M	$ -257.00K	$ -409.00K

Currency in USD

Zevra Therapeutics Earnings and Revenue History

Income Statement >

Zevra Therapeutics Debt to Assets

Balance Sheet >

Zevra Therapeutics Cash Flow

Cash Flow >

Zevra Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing